Surgery Partners EBITDA Margin 2013-2024 | SGRY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surgery Partners (SGRY) over the last 10 years. The current EBITDA margin for Surgery Partners as of September 30, 2024 is .
Surgery Partners EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $2.98B $0.49B 16.39%
2024-06-30 $2.89B $0.49B 16.90%
2024-03-31 $2.79B $0.49B 17.50%
2023-12-31 $2.74B $0.46B 16.77%
2023-09-30 $2.72B $0.45B 16.61%
2023-06-30 $2.66B $0.44B 16.60%
2023-03-31 $2.61B $0.42B 16.25%
2022-12-31 $2.54B $0.47B 18.59%
2022-09-30 $2.44B $0.48B 19.82%
2022-06-30 $2.38B $0.47B 19.75%
2022-03-31 $2.31B $0.45B 19.54%
2021-12-31 $2.22B $0.41B 18.57%
2021-09-30 $2.16B $0.40B 18.41%
2021-06-30 $2.10B $0.35B 16.77%
2021-03-31 $1.93B $0.34B 17.35%
2020-12-31 $1.86B $0.29B 15.54%
2020-09-30 $1.83B $0.26B 14.22%
2020-06-30 $1.79B $0.29B 16.47%
2020-03-31 $1.86B $0.30B 16.17%
2019-12-31 $1.83B $0.32B 17.64%
2019-09-30 $1.81B $0.20B 10.86%
2019-06-30 $1.79B $0.18B 10.08%
2019-03-31 $1.78B $0.17B 9.34%
2018-12-31 $1.77B $0.16B 8.75%
2018-09-30 $1.74B $0.29B 16.49%
2018-06-30 $1.61B $0.23B 14.50%
2018-03-31 $1.47B $0.22B 14.95%
2017-12-31 $1.34B $0.22B 16.12%
2017-09-30 $1.19B $0.19B 16.10%
2017-06-30 $1.16B $0.24B 20.29%
2017-03-31 $1.17B $0.25B 21.63%
2016-12-31 $1.15B $0.24B 21.12%
2016-09-30 $1.10B $0.20B 17.95%
2016-06-30 $1.06B $0.20B 18.68%
2016-03-31 $1.00B $0.19B 18.54%
2015-12-31 $0.96B $0.19B 19.69%
2015-06-30 $0.53B $0.12B 22.70%
Sector Industry Market Cap Revenue
Medical Medical Services $2.493B $2.743B
Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00